That’s why Hoth Therapeutics (HOTH), Saw happy endings of the year 2020

On the final day of 2020, Hoth Therapeutics (HOTH) shares closed above 44% to reach $2.37, and it stayed in green even in the after-hours session. As a biopharmaceutical company, it announced it had signed a production agreement with Tergus Pharma for HT-001, its new cancer treatment drug. This announcement follows the recent news that […]

Market Globalist
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.